5431-39-0 Usage
General Description
7-chloro-N-(4-chlorophenyl)quinolin-4-amine is a chemical compound with the molecular formula C15H9Cl2N3. It is a quinoline derivative that contains both chlorine and amine groups in its structure. 7-chloro-N-(4-chlorophenyl)quinolin-4-amine is commonly used in medicinal chemistry as a building block for the synthesis of various pharmaceuticals and agrochemicals. It has also been studied for its potential biological activities, including antimalarial and anticancer properties. Additionally, research has shown that it may possess anti-inflammatory and antimicrobial properties, making it a versatile and potentially useful chemical compound in various fields of science and medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 5431-39-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,3 and 1 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 5431-39:
(6*5)+(5*4)+(4*3)+(3*1)+(2*3)+(1*9)=80
80 % 10 = 0
So 5431-39-0 is a valid CAS Registry Number.
5431-39-0Relevant articles and documents
Preparation method of intermediate for leukemia treatment medicines
-
Paragraph 0071; 0072; 0073; 0074; 0075, (2019/01/23)
The invention belongs to the technical field of chemical medicines, and specifically relates to a preparation method of an intermediate for leukemia treatment medicines. The method comprises the stepsof supporting N-[3-(triethoxysilyl)propyl]-4,5-dihydroi
Structural optimization of quinolon-4(1 H)-imines as dual-stage antimalarials: Toward increased potency and metabolic stability
Ressurrei??o, Ana S.,Gon?alves, Daniel,Sitoe, Ana R.,Albuquerque, Ine?s S.,Gut, Jiri,Góis, Ana,Gon?alves, Lídia M.,Bronze, Maria R.,Hanscheid, Thomas,Biagini, Giancarlo A.,Rosenthal, Philip J.,Prude?ncio, Miguel,O'Neill, Paul,Mota, Maria M.,Lopes, Francisca,Moreira, Rui
supporting information, p. 7679 - 7690 (2013/11/06)
Discovery of novel effective and safe antimalarials has been traditionally focused on targeting erythrocytic parasite stages that cause clinical symptoms. However, elimination of malaria parasites from the human population will be facilitated by intervent
